PARP2 Chemiluminescent Assay Kit

The PARP2 Chemiluminescent Assay Kit is designed to measure the activity of PARP2 (poly- (ADP-ribose) polymerase 2) for screening and profiling applications. The PARP2 assay kit comes in a convenient 96-well or 384-well format, with enough recombinant purified PARP2 enzyme (amino acids 2-583), reaction substrates, and PARP assay buffer for 100 or 400 enzyme reactions.Figure 1. PARP2 Chemiluminescent Assay Kit schematic.Histone proteins are coated on a 384-well plate. Next, a biotinylated NAD+mix (termed PARP Substrate Mixture) is incubated with the PARP2 enzyme and an activated DNA template in an optimized assay buffer. The plate is then treated with streptavidin-HRP followed by addition of the ELISA ECL substrate to produce chemiluminescence that can be measured using a chemiluminescence reader. The chemiluminescence signal is proportional to PARP2 activity.This product has beencited 13 times.

Product Specifications

Background

PARP2, also known as poly- (ADP-ribose) polymerase 2 or NAD+ADP-ribosyltransferase 2, is part of the PARP family. ADP ribosylation, which is the addition of an ADP-ribose to a protein, is a reversible post-translational modification of proteins mostly involved in the DNA Damage Response (DDR) pathway. Poly-ADP-ribosylation (termed PARylation) is the addition of linear or branched chains of ADP-ribose. PARP2 participates in DNA repair (only 10% of the PARP activity is due to PARP2), but also in oxidative stress and mitochondrial fragmentation. Dysfunction of the DDR and oxidative stress pathways can lead to oncogenesis. Genetic ablation of PARP2 has indicated roles of PARP2 in adipogenesis, spermatogenesis and thymocyte survival. It is also a co-factor of nuclear receptors like ER (estrogen receptor) and PPAR (peroxisome proliferator-activated receptors) . PARP2 is overexpressed in prostate cancer (PCa) and may contribute to the disease through the FOXA1 (forkhead box protein A1) /AR pathway. PARP inhibitors have been used in cancer treatment with success, with the clinically approved inhibitors targeting both PARP1 and PARP2. Further understanding of the molecular pathways involving PARP2, and its contribution to disease, will continue to pave the way for new therapies for PARP2-linked diseases.

UniProt

Q9UGN5

Applications

Study enzyme kinetics and screen small molecule inhibitors for drug discovery and high throughput screening (HTS) applications.

Format

96 reactionsCatalog #NameAmountStorage80502PARP2, GST-Tag*1 µg-80°C520295x Histone Mixture1 ml-80°C78366PARP Substrate Mixture 12 x 250 µl-80°C8060210x PARP Assay Buffer1 ml-20°C79743Blocking Buffer 325 ml+4°C80605Activated DNA20 µl-80°C0.5 M DTT200 µl-20°C80611Streptavidin-HRP100 µl+4°C79670ELISA ECL Substrate A (translucent bottle) 6 mlRoom TempELISA ECL Substrate B (brown bottle) 6 mlRoom Temp7983796-well module plate1Room Temp*The concentration of the protein is lot-specific and will be indicated on the tube.384 reactionsCatalog #NameAmountStorage80502PARP2, GST-Tag*2 x 1 µg-80°C520295x Histone Mixture2 x 1 ml-80°C78366PARP Substrate Mixture 14 x 250 µl-80°C8060210x PARP Assay Buffer2 x 1 ml-20°C79743Blocking Buffer 32 x 25 ml+4°C80605Activated DNA2 x 20 µl-80°C0.5 M DTT2 x 200 µl-20°C80611Streptavidin-HRP2 x 100 µl+4°C79670ELISA ECL Substrate A (translucent bottle) 2 x 6 mlRoom TempELISA ECL Substrate B (brown bottle) 2 x 6 mlRoom Temp78188384-well white plate1Room Temp*The concentration of the protein is lot-specific and will be indicated on the tube

Shipping Conditions

-80°C

Storage Conditions

This assay kit will perform optimally for up to 6 months from date of receipt when the materials are stored as directed.

Notes

Troubleshooting GuideVisitbpsbioscience.com/assay-kits-faqfor detailed troubleshooting instructions. For all further questions, please email[email protected]